Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

GEORGE EDWARD MARK IV

Allopathic & Osteopathic Physicians Internal Medicine Clinical Cardiac Electrophysiology

NPI
1265516488
CMS profile
148423
Location
HADDON HEIGHTS, NJ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$34,511.86

133 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $18,675.00 9
Travel and Lodging $5,759.88 18
Food and Beverage $5,048.79 102
Honoraria $4,800.00 2
Education $228.19 2

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 133 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

GEORGE EDWARD MARK IV

NPI 1265516488 · CMS profile ID 148423

Allopathic & Osteopathic Physicians / Internal Medicine / Clinical Cardiac Electrophysiology

HADDON HEIGHTS, NJ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 133 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1265516488?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
GEORGE EDWARD MARK IV, NPI 1265516488, CMS profile ID 148423. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 133 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1265516488?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). GEORGE EDWARD MARK IV, NPI 1265516488, CMS profile ID 148423. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 133 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1265516488?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
GEORGE EDWARD MARK IV, NPI 1265516488, CMS profile ID 148423, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 133 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1265516488?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

133 matching records · $34,511.86 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 133 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 133.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ATRICURE, INC. $172.2906/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132855581 CMS
E.R. Squibb & Sons, L.L.C. $13.8606/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101350918 CMS
Ethicon US, LLC $28.9406/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1077639066 CMS
Impulse Dynamics (USA) Inc. $2.7606/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1100426290 CMS
Impulse Dynamics (USA) Inc. $73.6706/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1100426286 CMS
Boston Scientific Corporation $3.5306/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092261170 CMS
Abbott Laboratories $13.3506/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124935802 CMS
Abbott Laboratories $0.8006/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124935806 CMS
Boston Scientific Corporation $4.2406/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092261176 CMS
Boston Scientific Corporation $29.1106/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092261194 CMS
Boston Scientific Corporation $4.1106/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092261174 CMS
Edwards Lifesciences Corporation $21.7406/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138836306 CMS
Janssen Pharmaceuticals, Inc $13.6105/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078090866 CMS
Abbott Laboratories $84.1605/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124935832 CMS
Amgen Inc. $15.2205/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117619912 CMS
Abbott Laboratories $21.8905/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124935798 CMS
BIOTRONIK INC. $21.1505/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145802097 CMS
Biosense Webster, Inc. $28.3505/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1077699392 CMS
Boston Scientific Corporation $11.3805/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092261188 CMS
Impulse Dynamics (USA) Inc. $3.8905/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1100426325 CMS
Boston Scientific Corporation $4.3705/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092261178 CMS
Novartis Pharmaceuticals Corporation $14.2505/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087049906 CMS
Abbott Laboratories $135.4505/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124935795 CMS
Abbott Laboratories $114.4204/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124935791 CMS
Biosense Webster, Inc. $26.0904/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1077699397 CMS
Kiniksa Pharmaceuticals International, plc $14.5904/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154885114 CMS
Boston Scientific Corporation $3.8204/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092261172 CMS
BIOTRONIK INC. $14.0104/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145802089 CMS
Abbott Laboratories $587.5004/23/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125398810 CMS
Boston Scientific Corporation $21.7704/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092261192 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $18.9504/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1080607101 CMS
Abbott Laboratories $4,000.0004/22/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125398814 CMS
Abbott Laboratories $284.7804/16/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125398812 CMS
Impulse Dynamics (USA) Inc. $31.2004/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1100426320 CMS
E.R. Squibb & Sons, L.L.C. $300.0004/12/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101350964 CMS
Abbott Laboratories $250.9204/10/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125398816 CMS
Boston Scientific Corporation $9.3704/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092261184 CMS
Abbott Laboratories $22.5904/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124935776 CMS
Abbott Laboratories $6.7204/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124935779 CMS
Abbott Laboratories $116.8304/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124935783 CMS
Abbott Laboratories $3.2304/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124935787 CMS
Abbott Laboratories $10.1103/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124935772 CMS
ATRICURE, INC. $39.4603/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132863662 CMS
Abbott Laboratories $128.6403/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124935745 CMS
Boston Scientific Corporation $2,000.0003/15/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092261162 CMS
Abbott Laboratories $9.0203/13/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125398830 CMS
Abbott Laboratories $110.1903/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124935768 CMS
CVRx, Inc. $16.1703/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133235726 CMS
CVRx, Inc. $7.7703/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133235724 CMS
Abbott Laboratories $7.2003/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124935757 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $100,952.01 239
PY2020 $31,559.35 164
PY2021 $30,897.07 186
PY2022 $60,553.17 192
PY2023 $53,367.72 183
PY2024 $34,511.86 133

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $83,259.35 9
PY2024 Principal investigator $149,849.90 30
PY2023 Principal investigator $36,701.65 19
PY2022 Principal investigator $38,050.10 24
PY2021 Principal investigator $129,596.57 41
PY2020 Principal investigator $59,439.85 42
PY2019 Principal investigator $125,768.95 79

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

9 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $4,680.00 06/23/2025 Non-covered Recipient Entity
Crdvsclr Associates Of The Delaware Vly
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175244587
Principal investigator 1 Janssen Research & Development, LLC $8,303.00 06/20/2025 Non-covered Recipient Entity
Crdvsclr Associates Of The Delaware Vly
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175244594
Principal investigator 1 Impulse Dynamics (USA) Inc. $2,015.00 06/12/2025 Non-covered Recipient Entity
Cardiovascular Assoc Delaware Valley - CADV
Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) No dispute reported 06/30/2026 1214122017
Principal investigator 1 Janssen Research & Development, LLC $2,337.00 05/21/2025 Non-covered Recipient Entity
Crdvsclr Associates Of The Delaware Vly
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175244625
Principal investigator 1 Janssen Research & Development, LLC $13,308.00 04/23/2025 Non-covered Recipient Entity
Crdvsclr Associates Of The Delaware Vly
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175244630
Principal investigator 1 Janssen Research & Development, LLC $3,930.00 03/21/2025 Non-covered Recipient Entity
Crdvsclr Associates Of The Delaware Vly
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175244570
Principal investigator 1 Janssen Research & Development, LLC $17,798.00 02/19/2025 Non-covered Recipient Entity
Crdvsclr Associates Of The Delaware Vly
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175244608
Principal investigator 1 Janssen Research & Development, LLC $29,073.00 01/22/2025 Non-covered Recipient Entity
Crdvsclr Associates Of The Delaware Vly
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175244579
Principal investigator 1 Boston Scientific Corporation $1,815.35 01/14/2025 Non-covered Recipient Entity
CARDIOVASCULAR ASSOCIATES OF THE DELAWARE VALLEY P A
ASAP- TOO No dispute reported 06/30/2026 1207582939